Nanoparticles for esophagus cancer detection by CLE

Abstract: For many years, novel strategies for cancer detection and treatment using nanoparticles (NPs) have been developed. Read this original research and sign up to receive International Journal of Nanomedicine here: https://www.dovepress.com/articles.php?article_id=24392
Dove Medical Press8 Pins77 Followers
Figure 5 Endoscopic view, histology, and confocal imaging of rat esophageal mucosa before NP administration.

Figure 5 Endoscopic view, histology, and confocal imaging of rat esophageal mucosa before NP administration.

Figure 1 Schematic representation of the organic fluorescent nanoparticles.

Figure 1 Schematic representation of the organic fluorescent nanoparticles.

Figure 2 Schematic drawing of microfluidic precipitation device.

Figure 2 Schematic drawing of microfluidic precipitation device.

Figure 3 Characterization of NPs-DCM-ASYNYDA nanoparticles by MALDI-TOF/TOF analysis.

Figure 3 Characterization of NPs-DCM-ASYNYDA nanoparticles by MALDI-TOF/TOF analysis.

Figure 4 Size distribution of fluorescent polysaccharide NPs.

Figure 4 Size distribution of fluorescent polysaccharide NPs.

Figure 6 Confocal imaging of rat esophageal adenocarcinoma upon intravenous administration of NPs.

Figure 6 Confocal imaging of rat esophageal adenocarcinoma upon intravenous administration of NPs.

Figure S1 Fluorescence excitation (blue line) and emission (red line) spectra of NP-DCM nanoparticles in saline buffer...

Figure S1 Fluorescence excitation (blue line) and emission (red line) spectra of NP-DCM nanoparticles in saline buffer...

Figure S2 NP-DCM-ASYNYDA binds to human esophageal carcinoma cells.

Figure S2 NP-DCM-ASYNYDA binds to human esophageal carcinoma cells.

Pinterest
Search